ℹ️ Medical Disclaimer: This page reports what a published FDA label says. It is not medical advice and it does not interpret any warning for an individual. Always consult your physician or pharmacist before changing a medication. Full disclosure policy.

Yes. 5 FDA-approved labels for Thioridazine carry a boxed warning, and its subject is thioridazine has been shown to prolong the qtc interval in a dose related manner, and drugs with this potential, including.... A boxed warning is the most serious warning the FDA requires on a prescription label. It is applied to the drug and to the situations in which it is used, not to any particular person taking it.

5
FDA labels carrying this warning
1
wording, shared by all 5 labels sampled
100%
used the wording quoted below

What the warning says

Below is how the Thioridazine warning opens on one specific label, identified underneath it. All 5 Thioridazine labels sampled carried this same wording, which is unusual: most drugs show several.

WARNING Thioridazine has been shown to prolong the QTc interval in a dose related manner, and drugs with this potential, including thioridazine, have been associated